SLDB
NASD Solid Biosciences Inc.$6.85 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.85, $0.41 below the day’s high of $7.26
- YTD change
- +21.45%
- vs 20-day SMA
- -19.61%
- vs 200-day SMA
- -9.69%
Price ranges
Price & Performance
-0.89 (-11.50%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.2% away from all-time highs of $822.60
- SLDB is up 21% since the beginning of the year
- SLDB is up 19% over the past 12 months
- SLDB is down 33% over the past 1 month
- 13% of all SLDB investors are betting against SLDB
SLDB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +16.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -8.42%
- vs 8-day SMA
- -9.21%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.